Syed Yousuf Zafar, MD

Adjunct Professor in the Department of Medicine
Affiliate, Duke Global Health Institute
Core Faculty Member, Duke-Margolis Center for Health Policy
Associate of the Duke Initiative for Science & Society
Member of the Duke Cancer Institute
Member in the Duke Clinical Research Institute
Campus mail Duke Box 3505, Durham, NC 27710
Phone (919) 684-8111
Email address yousuf.zafar@duke.edu

Dr. Zafar is a gastrointestinal medical oncologist and Associate Professor of Medicine, Public Policy, and Population Health Science at the Duke Cancer Institute and Duke-Margolis Center for Health Policy. He serves as Director of Healthcare Innovation at the Duke Cancer Institute. Dr. Zafar also serves as Clinical Associate Director of Duke Forge (Health Data Science Center). Dr. Zafar is considered an international expert in identifying and intervening upon the financial burden of cancer care. His research explores ways to improve cancer care delivery with a primary focus on improving the value of cancer treatment from both patient-focused and policy perspectives.

Dr. Zafar speaks internationally on his research and cancer care delivery. He has over 100 publications in top peer-reviewed journals including the New England Journal of Medicine, the Journal of Clinical Oncology, and JAMA Oncology. His research has been funded by the National Institutes of Health and the American Cancer Society, among others. His work has been covered by national media outlets including New York Times, Forbes, Wall Street Journal, NPR, and Washington Post. He is a Fellow of the American Society of Clinical Oncology.

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 2005 - 2008
  • Resident, Medicine, University of Cincinnati, 2002 - 2005
  • M.D., The University of Toledo, 2002

Publications

Zafar, Y., and H. I. Hurwitz. “Monoclonal antibodies to EGFR: What does the future hold?” Oncology 21, no. 8 (July 1, 2007): 976–77.

Scholars@Duke

Zafar, Yousuf, and Herbert I. Hurwitz. “Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed.” Oncology New York 21, no. 8 (July 1, 2007): 976–77.

Scholars@Duke

Pages